![Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination | Nature Medicine Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-022-01705-6/MediaObjects/41591_2022_1705_Fig1_HTML.png)
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination | Nature Medicine
![Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people - The Lancet Infectious Diseases Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/70ac421e-169c-4581-b03c-4ee839310ea2/gr1.jpg)
Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people - The Lancet Infectious Diseases
![Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - The Lancet Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - The Lancet](https://www.thelancet.com/cms/attachment/a112b216-fe27-4168-bf81-0d5f148da2a9/gr2_lrg.jpg)
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - The Lancet
![CORBEVAX gets EUA from Health Ministry as heterologous COVID-19 booster shot for 18 years and above - Express Pharma CORBEVAX gets EUA from Health Ministry as heterologous COVID-19 booster shot for 18 years and above - Express Pharma](https://cdn.expresspharma.in/wp-content/uploads/2022/02/22114135/CORBEVAX_small2.jpg)
CORBEVAX gets EUA from Health Ministry as heterologous COVID-19 booster shot for 18 years and above - Express Pharma
![Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries - ScienceDirect Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X23011817-gr1.jpg)
Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries - ScienceDirect
![Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial - The Lancet Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial - The Lancet](https://www.thelancet.com/cms/asset/3b4eb078-d7dd-4a37-98ea-553c444f2a49/gr1.jpg)
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial - The Lancet
![ET NOW on X: "News Alert | Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per dose (From Agencies) #Covid19 #Covovax #CoWIN https://t.co/OpNgyiWljI" / ET NOW on X: "News Alert | Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per dose (From Agencies) #Covid19 #Covovax #CoWIN https://t.co/OpNgyiWljI" /](https://pbs.twimg.com/media/FtWWUMkaIAAppPE.jpg:large)
ET NOW on X: "News Alert | Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per dose (From Agencies) #Covid19 #Covovax #CoWIN https://t.co/OpNgyiWljI" /
![Frontiers | The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China Frontiers | The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China](https://www.frontiersin.org/files/Articles/943876/fpubh-10-943876-HTML/image_m/fpubh-10-943876-g002.jpg)
Frontiers | The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China
![Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2 Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2](https://pub.mdpi-res.com/vaccines/vaccines-10-02146/article_deploy/html/images/vaccines-10-02146-g003.png?1671532649)
Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
![Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study | The BMJ Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study | The BMJ](https://www.bmj.com/content/bmj/378/bmj-2022-070483/F3.medium.jpg)
Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study | The BMJ
What is a COVID-19 Heterologous Booster? | What is a #COVID19 Heterologous Booster? Also called a “mix and match” #booster dose, the CDC is allowing eligible individuals to choose which COVID-19...
![Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study - สมาคมโรคตับแห่งประเทศไทย Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study - สมาคมโรคตับแห่งประเทศไทย](https://thasl.org/wp-content/uploads/2023/09/%E0%B8%97%E0%B8%B8%E0%B8%99%E0%B8%A7%E0%B8%B4%E0%B8%88%E0%B8%B1%E0%B8%A2%E0%B8%AA%E0%B8%A1%E0%B8%B2%E0%B8%84%E0%B8%A1%E0%B9%82%E0%B8%A3%E0%B8%84%E0%B8%95%E0%B8%B1%E0%B8%9A-%E0%B8%AD.%E0%B8%AD%E0%B8%A0%E0%B8%B4%E0%B8%8A%E0%B8%B2%E0%B8%95%E0%B8%B4-thumb.jpg)
Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study - สมาคมโรคตับแห่งประเทศไทย
![Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2 Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2](https://www.mdpi.com/vaccines/vaccines-10-02146/article_deploy/html/images/vaccines-10-02146-g001a.png)
Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
SII seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adults, ET HealthWorld
![Comparing the SARS-CoV-2-specific antibody response in human milk after homologous and heterologous booster vaccinations | Communications Biology Comparing the SARS-CoV-2-specific antibody response in human milk after homologous and heterologous booster vaccinations | Communications Biology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs42003-023-04455-4/MediaObjects/42003_2023_4455_Fig1_HTML.png)
Comparing the SARS-CoV-2-specific antibody response in human milk after homologous and heterologous booster vaccinations | Communications Biology
![Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses | The BMJ Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses | The BMJ](https://www.bmj.com/content/bmj/382/bmj-2022-074325/F6.medium.jpg)
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses | The BMJ
![Unravelling the enhanced vaccine immunity by heterologous KCONVAC/Ad5-nCoV COVID-19 vaccination | Signal Transduction and Targeted Therapy Unravelling the enhanced vaccine immunity by heterologous KCONVAC/Ad5-nCoV COVID-19 vaccination | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-022-01079-8/MediaObjects/41392_2022_1079_Fig1_HTML.png)